Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study
RA Krasuski, D Doeppenschmidt, JS Henry… - Mayo Clinic …, 2005 - Elsevier
OBJECTIVE To examine the safety and efficacy of switching from simvastatin to atorvastatin
in patients who had either an inadequate lipid-lowering response with, or an adverse …
in patients who had either an inadequate lipid-lowering response with, or an adverse …
Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study
RA Krasuski, D Doeppenschmidt, JS Henry… - Mayo Clinic …, 2005 - infona.pl
To examine the safety and efficacy of switching from simvastatin to atorvastatin in patients
who had either an inadequate lipid-lowering response with, or an adverse reaction to …
who had either an inadequate lipid-lowering response with, or an adverse reaction to …
[PDF][PDF] Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study
RA KRASUSKI, D DOEPPENSCHMIDT, JS HENRY… - Mayo Clin …, 2005 - academia.edu
OBJECTIVE: To examine the safety and efficacy of switching from simvastatin to atorvastatin
in patients who had either an inadequate lipid-lowering response with, or an adverse …
in patients who had either an inadequate lipid-lowering response with, or an adverse …
Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study
RA Krasuski, D Doeppenschmidt… - Mayo Clinic …, 2005 - search.proquest.com
to Simvastatin Therapy: The CAPISH Study Page 1 ORIGINAL ARTICLE Conversion to
Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study …
Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study …
Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study.
RA Krasuski, D Doeppenschmidt, JS Henry… - Mayo Clinic …, 2005 - europepmc.org
Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH
study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study
RA Krasuski, D Doeppenschmidt… - Mayo Clinic …, 2005 - mayoclinicproceedings.org
OBJECTIVE To examine the safety and efficacy of switching from simvastatin to atorvastatin
in patients who had either an inadequate lipid-lowering response with, or an adverse …
in patients who had either an inadequate lipid-lowering response with, or an adverse …
Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study.
RA Krasuski, D Doeppenschmidt, JS Henry, PB Smith… - 2005 - cabidigitallibrary.org
OBJECTIVE: To examine the safety and efficacy of switching from simvastatin to atorvastatin
in patients who had either an inadequate lipid-lowering response with, or an adverse …
in patients who had either an inadequate lipid-lowering response with, or an adverse …
[引用][C] Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: The CAPISH study
RA KRASUSKI, D DOEPPENSCHMIDT… - Mayo Clinic …, 2005 - pascal-francis.inist.fr
Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy : The
CAPISH study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
CAPISH study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study
RA Krasuski, D Doeppenschmidt… - Mayo Clinic …, 2005 - pubmed.ncbi.nlm.nih.gov
Objective To examine the safety and efficacy of switching from simvastatin to atorvastatin in
patients who had either an inadequate lipid-lowering response with, or an adverse reaction …
patients who had either an inadequate lipid-lowering response with, or an adverse reaction …
[PDF][PDF] Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study
RA KRASUSKI, D DOEPPENSCHMIDT, JS HENRY… - Mayo Clin …, 2005 - academia.edu
OBJECTIVE: To examine the safety and efficacy of switching from simvastatin to atorvastatin
in patients who had either an inadequate lipid-lowering response with, or an adverse …
in patients who had either an inadequate lipid-lowering response with, or an adverse …